SINGAPORE,Feb. 25,2025-- ADA,a leader in data and AI-driven digital transformation and all-in-one authentication solutions,and IPification,a pioneer in seamless mobile authentication,have announced t

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid

SHANGHAI,Feb. 25,2025-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm

-Earnings Webinar Scheduled for 6:00 a.m. ET on March 18,2025- GUANGZHOU,China,Feb. 25,2025--HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA),a leading game live streaming platform

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned